Seminar at Roswell Park Cancer Institute
RNAscope™ assay is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells.
Using RNAscope™ assay you can:
- Detect single RNA molecule at single-cell resolution in a single-day
- Asses splice variants, highly homologous sequences, lncRNA, and targets lacking IHC antibodies
- Analyze tumor heterogeneity using Dual ISH-IHC and Multiplex assays
This enables researchers to visualize genes that are expressed, localize where they are expressed in any complex tissue from any species. The RNAscope™ technology is proven and published in over 900 publications in various research areas such as neuroscience, immuno-oncology, infectious disease and stem cell. This technology is commonly used for dual ISH-IHC analysis, RNA-Seq validation, single-cell analysis, and recently introduce BaseScope™ assay makes detection of exon junctions and highly homologous targets also possible.
